Immune-mediated adverse events following influenza vaccine in cancer patients receiving immune checkpoint inhibitors
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immune-mediated adverse events following influenza vaccine in cancer patients receiving immune checkpoint inhibitors
Authors
Keywords
-
Journal
JOURNAL OF ONCOLOGY PHARMACY PRACTICE
Volume -, Issue -, Pages 107815521986875
Publisher
SAGE Publications
Online
2019-08-31
DOI
10.1177/1078155219868758
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
- (2018) Julie R. Brahmer et al. JOURNAL OF CLINICAL ONCOLOGY
- Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events
- (2018) Heinz Läubli et al. Journal for ImmunoTherapy of Cancer
- Safety of influenza vaccination in patients undergoing immunotherapy treatment for advanced cancer.
- (2018) Curtis Robert Chong et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of the influenza vaccination on cancer patients undergoing therapy with immune checkpoint inhibitors (ICI).
- (2018) Ragisha Gopalakrishnan et al. JOURNAL OF CLINICAL ONCOLOGY
- Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
- (2017) Padmanee Sharma et al. LANCET ONCOLOGY
- Elements of cancer immunity and the cancer–immune set point
- (2017) Daniel S. Chen et al. NATURE
- Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
- (2017) Joaquim Bellmunt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interstitial nephritis in melanoma patients secondary to PD-1 checkpoint inhibitor
- (2017) Julia Escandon et al. Journal for ImmunoTherapy of Cancer
- Immune-related adverse events with immune checkpoint blockade: a comprehensive review
- (2016) J.M. Michot et al. EUROPEAN JOURNAL OF CANCER
- Serologic response and clinical efficacy of influenza vaccination in children and young adults on chemotherapy for cancer
- (2016) Daniel K. Choi et al. PEDIATRIC BLOOD & CANCER
- PD-1 Pathway Inhibitors: Immuno-Oncology Agents for Restoring Antitumor Immune Responses
- (2016) Patrick J. Medina et al. PHARMACOTHERAPY
- Influenza vaccination during the first 6 months after solid organ transplantation is efficacious and safe
- (2015) P. Pérez-Romero et al. CLINICAL MICROBIOLOGY AND INFECTION
- Immune Checkpoint Inhibitors: New Insights and Current Place in Cancer Therapy
- (2015) Ninh M. La-Beck et al. PHARMACOTHERAPY
- Practical review of immunizations in adult patients with cancer
- (2015) Ella J Ariza-Heredia et al. Human Vaccines & Immunotherapeutics
- Ipilimumab Increases Activated T Cells and Enhances Humoral Immunity in Patients With Advanced Melanoma
- (2011) Jeffrey S. Weber et al. JOURNAL OF IMMUNOTHERAPY
- Inflammatory responses to trivalent influenza virus vaccine among pregnant women
- (2011) Lisa M. Christian et al. VACCINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More